Drug · DIN 02443805
CYRAMZA
SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 10, 2015; first marketed September 10, 2015.
- Drug Identification Number (DIN)
- 02443805
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Ramucirumab L01FG02
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RAMUCIRUMAB | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 16, 2015: NOC 17127New Drug Submission (NDS)